Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,328 INR | +1.54% |
|
+2.31% | +11.00% |
Jun. 26 | Indian Equities Close Higher Midweek, Aided by Banking, Media and Oil & Gas Stocks | MT |
Jun. 17 | Fortis, Apollo, Medanta, and Max Lead the Charge in Bidding War for Jaypee Healthcare | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 96.66 and 61.03 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.00% | 10.9B | - | ||
-35.02% | 13.15B | B+ | ||
+4.81% | 11.82B | B+ | ||
-3.60% | 11.65B | B | ||
+27.77% | 8.58B | B | ||
-10.66% | 7.25B | A- | ||
+12.82% | 7.15B | B- | ||
+9.12% | 6.51B | D | ||
+10.13% | 4.17B | B+ | ||
+32.07% | 4.07B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- APOLLOHOSP Stock
- APOLLOHOSP Stock
- Ratings Apollo Hospitals Enterprise Limited